It is reported that apoE increased expression of miR-146a to suppress NF-κB-driven inflammation and atherosclerosis in macrophages and monocytes [36], which implies that miR-146a suppresses inflammation during hyperlipidemia to attenuate atherosclerosis. Here, NFKB1 is linked to hyperlipidemia.